FDA Clears Illumina's BeadXpress System for Clinical Use

CEO Jay Flatley called the clearance of BeadXpress for use in in vitro diagnostics a "significant and exciting transitional step" for the company into the diagnostics market.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.